> Details

Lumley, Sheila F; Wei, Jia; O’Donnell, Denise; Stoesser, Nicole E; Matthews, Philippa C; Howarth, Alison; Hatch, Stephanie B; Marsden, Brian D; Cox, Stuart; James, Tim; Peck, Liam J; Ritter, Thomas G; de Toledo, Zoe; Cornall, Richard J; Jones, E Yvonne; Stuart, David I; Screaton, Gavin; Ebner, Daniel; Hoosdally, Sarah; Crook, Derrick W; Conlon, Christopher P; Pouwels, Koen B; Walker, A Sarah; Peto, Tim E A; [...]

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
  • Contributor: Lumley, Sheila F; Wei, Jia; O’Donnell, Denise; Stoesser, Nicole E; Matthews, Philippa C; Howarth, Alison; Hatch, Stephanie B; Marsden, Brian D; Cox, Stuart; James, Tim; Peck, Liam J; Ritter, Thomas G; de Toledo, Zoe; Cornall, Richard J; Jones, E Yvonne; Stuart, David I; Screaton, Gavin; Ebner, Daniel; Hoosdally, Sarah; Crook, Derrick W; Conlon, Christopher P; Pouwels, Koen B; Walker, A Sarah; Peto, Tim E A; [...]
  • imprint: Oxford University Press (OUP), 2021
  • Published in: Clinical Infectious Diseases
  • Language: English
  • DOI: 10.1093/cid/ciab004
  • ISSN: 1058-4838; 1537-6591
  • Keywords: Infectious Diseases ; Microbiology (medical)
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody measurements can be used to estimate the proportion of a population exposed or infected and may be informative about the risk of future infection. Previous estimates of the duration of antibody responses vary.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>We present 6 months of data from a longitudinal seroprevalence study of 3276 UK healthcare workers (HCWs). Serial measurements of SARS-CoV-2 anti-nucleocapsid and anti-spike IgG were obtained. Interval censored survival analysis was used to investigate the duration of detectable responses. Additionally, Bayesian mixed linear models were used to investigate anti-nucleocapsid waning.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Anti-spike IgG levels remained stably detected after a positive result, for example, in 94% (95% credibility interval [CrI] 91–96%) of HCWs at 180 days. Anti-nucleocapsid IgG levels rose to a peak at 24 (95% CrI 19–31) days post first polymerase chain reaction (PCR)-positive test, before beginning to fall. Considering 452 anti-nucleocapsid seropositive HCWs over a median of 121 days from their maximum positive IgG titer, the mean estimated antibody half-life was 85 (95% CrI 81–90) days. Higher maximum observed anti-nucleocapsid titers were associated with longer estimated antibody half-lives. Increasing age, Asian ethnicity, and prior self-reported symptoms were independently associated with higher maximum anti-nucleocapsid levels and increasing age and a positive PCR test undertaken for symptoms with longer anti-nucleocapsid half-lives.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>SARS-CoV-2 anti-nucleocapsid antibodies wane within months and fall faster in younger adults and those without symptoms. However, anti-spike IgG remains stably detected. Ongoing longitudinal studies are required to track the long-term duration of antibody levels and their association with immunity to SARS-CoV-2 reinfection.</jats:p> </jats:sec>
  • Access State: Open Access